Nov. 26 at 8:30 PM
Cannabis stocks rose Wednesday after a Bloomberg report said U.S. Medicare may soon cover CBD treatments for certain patients, opening a new potential revenue stream for the sector. CMS is reportedly preparing an initiative that would make some Medicare patients—especially seniors in oncology and palliative-care settings—eligible for CBD coverage.
CBD is a non-psychoactive cannabis compound used for conditions such as cancer symptoms, sleep disorders, anxiety, pain, and inflammation. The report added that CBD advocate and payments financier Howard Kessler met with HHS Secretary Robert F. Kennedy Jr. last month. A CMS spokesperson declined to comment on potential actions. Cannabis stocks also surged in September after President Trump posted a video supporting Medicare coverage for CBD.
$ACB $IIPR $CRON $TLRY